SCHEMBL4146583

SCHEMBL4146583

CCNC(=O)c1ccc(Cl)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.69
KMT2A Q03164 5/20 0.69
MAPT P10636 3/20 0.69
LMNA P02545 2/20 0.69
HPGD P15428 1/20 0.69
CYP1A2 P05177 3/20 0.61
TSHR P16473 1/20 0.61
NFKB1 P19838 1/20 0.61
MAOB P27338 1/20 0.61
KDM4E B2RXH2 2/20 0.61
ALDH1A1 P00352 2/20 0.61
L3MBTL1 Q9Y468 1/20 0.61
GAA P10253 2/20 0.61
POLB P06746 1/20 0.61
CTDSP1 Q9GZU7 1/20 0.61
BLM P54132 1/20 0.59
PMP22 Q01453 1/20 0.59
HTT P42858 1/20 0.59
SMN1; SMN2 Q16637 3/20 0.56
CYP2C19 P33261 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8424856 0.94 MEN1 (0.63) MEN1KMT2AMAPTLMNAHPGD
SCHEMBL5909057 0.89 CA12 (0.58) MEN1KMT2AMAPTLMNAHPGD
Trifluoroacetic Acid SCHEMBL30664874 0.88 MEN1 (0.57) MEN1KMT2AMAPTLMNAHPGD
Chlorobenzene SCHEMBL27766061 0.84 NPC1 (0.55) MEN1KMT2AMAPTLMNAHPGD
SCHEMBL6359975 0.84 CYP1A2 (0.68) MEN1KMT2AMAPTLMNACYP1A2
SCHEMBL8235829 0.83 ALDH1A1 (0.66) MEN1KMT2AMAPTLMNAHPGD
SCHEMBL10873630 0.83 CYP1A2 (0.62) MEN1KMT2AMAPTLMNAHPGD
Chlorobenzene SCHEMBL28001559 0.83 LMNA (0.52) MEN1KMT2AMAPTLMNAHPGD
Chlorobenzene SCHEMBL27766117 0.83 SLC6A9 (0.55) MEN1KMT2AMAPTLMNAHPGD
Morpholine SCHEMBL28644462 0.83 LMNA (0.52) MEN1KMT2AMAPTLMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0751123-B1 Method for producing alkylsulfinylbenzamides SUMITOMO SEIKA CHEMICALS (JP) 2000-05-10 EP claimed
US-5672751-A TREATMENT OF A HALOBENZAMIDE WITH AN ALKANETHIOL IN THE PRESENCE OF A PHASE TRANSFER CATALYST SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 1997-09-30 US claimed
EP-0751123-A2 Method for producing alkylsulfinylbenzamides SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 1997-01-02 EP claimed
EP-0657438-A2 Method for producing alkylsulfinylbenzamides and 1,2-benzisothiazol-3-ones SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 1995-06-14 EP claimed
US-12152049-B2 STING agonistic compound ONO PHARMACEUTICAL CO., LTD. (JP) 2024-11-26 US disclosed
US-20230339992-A1 STING AGONISTIC COMPOUND ONO PHARMACEUTICAL CO., LTD. (JP) 2023-10-26 US disclosed
EP-4120837-A1 INHIBITORS OF CYTOKININ OXIDASE DERIVED FROM 2-(3-PHENYLUREIDO)BENZAMIDE, USE THEREOF AND PREPARATIONS CONTAINING THESE DERIVATIVES Univerzita Palackého v Olomouci (CZ) 2023-01-25 EP disclosed
WO-2021032648-A1 COMPOUNDS FOR USE IN THE TREATMENT OF LIVER DISEASE THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, & THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY AND UNDIV. TRINITY OF QUEEN (IE) 2021-02-25 WO disclosed
US-10654845-B2 2-(het)aryl-substituted fused bicyclic heterocycle derivatives as pesticides BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2020-05-19 US disclosed
US-10022354-B2 Pyrrolidine amide compounds as histone demethylase inhibitors GENENTECH, INC. (US) 2018-07-17 US disclosed
US-20180016273-A1 2-(HET)ARYL-SUBSTITUTED FUSED BICYCLIC HETEROCYCLE DERIVATIVES AS PESTICIDES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2018-01-18 US disclosed
US-20170312252-A1 PYRROLIDINE AMIDE COMPOUNDS AS HISTONE DEMETHYLASE INHIBITORS WUXI APPTEC (SHANGHAI) CO. LTD (CN) 2017-11-02 US disclosed
US-4151351-A PROSTAGLANDINS, ANTIINFLAMMATORY THE UPJOHN COMPANY (US) 1979-04-24 US disclosed
US-4131738-A 6-Hydroxy-PGE1 compounds THE UPJOHN COMPANY (US) 1978-12-26 US disclosed
US-4128713-A 6,7-Didehydro-PGI1 compounds THE UPJOHN COMPANY (US) 1978-12-05 US disclosed
US-4126744-A PROSTACYCLIN, MUSCLE STIMULANTS, PLATELET AGGREGATION INHIBITORS THE UPJOHN COMPANY (US) 1978-11-21 US disclosed
US-4112224-A PROSTAGLANDIN THE UPJOHN COMPANY (US) 1978-09-05 US disclosed
US-4109082-A PROSTACYCLIN ANALOGS; SMOOTH MUSCLE STIMULATORS THE UPJOHN COMPANY (US) 1978-08-22 US disclosed
US-4100192-A Inter-phenylene-PG amides THE UPJOHN COMPANY (US) 1978-07-11 US disclosed
US-4097489-A PROSTAGLANDINS THE UPJOHN COMPANY (US) 1978-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180016273-A1 2-(HET)ARYL-SUBSTITUTED FUSED BICYCLIC HETEROCYCLE DERIVATIVES AS PESTICIDES CYP4B1, CYP1B1, CYP8B1 MEN1 2151/4885KMT2A 1263/4885MAPT 4794/4885
US-10654845-B2 2-(het)aryl-substituted fused bicyclic heterocycle derivatives as pesticides CYP4B1, CYP1B1, CYP8B1 MEN1 2209/4885KMT2A 1302/4885MAPT 4797/4885
US-20170312252-A1 PYRROLIDINE AMIDE COMPOUNDS AS HISTONE DEMETHYLASE INHIBITORS KDM5A, KDM5C, KDM5B MEN1 3356/4885KMT2A 34/4885MAPT 2124/4885
US-10022354-B2 Pyrrolidine amide compounds as histone demethylase inhibitors KDM5A, KDM5C, KDM1B MEN1 3483/4885KMT2A 35/4885MAPT 2084/4885
US-12152049-B2 STING agonistic compound STING1, IRF3, MAVS MEN1 295/4885KMT2A 2971/4885MAPT 4099/4885
US-20230339992-A1 STING AGONISTIC COMPOUND STING1, IRF3, MAVS MEN1 295/4885KMT2A 2971/4885MAPT 4099/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.